United States Pharmaceuticals

Chiasma Inc (CHMA)

Track

Ticker: CHMA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Mamluk Roni
1 sale — total 139,905 USD
Planned sale 9 Feb 2021
Value US$2,770,306.54 | Price 72.90 | Shares 10,201
Buy 30 Nov 2020
Value US$4,417,825.78 | Price 331.94 | Shares 12,982
Buy 23 Nov 2020
Value US$480,492.00 | Price 4.00 | Shares 120,000
Buy 14 Jul 2020
Value US$42,000.00 | Price 4.20 | Shares 10,000
Planned sale 20 Feb 2020
Value US$373,124.44 | Price 4.54 | Shares 82,186
Planned sale 20 Dec 2019
Value US$336,875.89 | Price 5.51 | Shares 61,139
Planned sale 16 Oct 2019
Value US$49,400.00 | Price 4.94 | Shares 10,000
Buy 27 Sep 2019
Value US$24,783.38 | Price 4.91 | Shares 5,050
Planned sale 20 Sep 2019
Value US$279,500.00 | Price 5.59 | Shares 50,000
Buy 20 Aug 2019
Value US$29,410.94 | Price 5.33 | Shares 5,518
Buy 19 Aug 2019
Value US$21,586.00 | Price 5.02 | Shares 4,300
Planned sale 16 Jul 2019
Value US$63,500.00 | Price 6.35 | Shares 10,000
Planned sale 16 Apr 2019
Value US$53,100.00 | Price 5.31 | Shares 10,000
Planned buy 1 Apr 2019
Value US$8,125.00 | Price 5.00 | Shares 1,625
Planned sale 5 Mar 2019
Value US$25,000.00 | Price 5.00 | Shares 5,000
Planned sale 22 Jan 2019
Value US$18,370.00 | Price 3.67 | Shares 5,000
Planned buy 20 Dec 2018
Value US$24,030.00 | Price 2.50 | Shares 9,612
Buy 20 Sep 2018
Value US$40,170.00 | Price 3.09 | Shares 13,000
Buy 19 Sep 2018
Value US$24,480.00 | Price 3.06 | Shares 8,000
Buy 18 Sep 2018
Value US$12,280.00 | Price 3.07 | Shares 4,000
Planned sale 18 Jun 2018
Value US$3,484.12 | Price 1.46 | Shares 2,389
Planned sale 19 Mar 2018
Value US$3,655.17 | Price 1.53 | Shares 2,389
Planned sale 18 Dec 2017
Value US$4,180.75 | Price 1.75 | Shares 2,389
Planned sale 24 Oct 2017
Value US$5,430.20 | Price 2.27 | Shares 2,389
Buy 21 Sep 2017
Value US$23,569.00 | Price 2.36 | Shares 10,000
Buy 20 Sep 2017
Value US$35,689.50 | Price 2.38 | Shares 15,000
Buy 21 Jul 2015
Value US$1,500,000.00 | Price 16.00 | Shares 93,750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-11 2021-02-09 PlS Planned sale
Mamluk Roni
Non-Executive Director
10,201 +34.8%
72.90
US$2,770,307 		10,201 +34.8% 72.90 US$2,770,307
2020-12-01 2020-11-30 B Purchase
2.8
STACK DAVID M
Non-Executive Director
12,982 +11.4%
331.94
US$4,417,826 		12,982 +11.4% 331.94 US$4,417,826
2020-11-24 2020-11-23 B Purchase
KANNAN RAJ

Chief Executive Officer

Executive Director
13,197 -16.3%
346.35
US$1,907,021 		13,197 -16.3% 346.35 US$1,907,021
2020-07-15 2020-07-14 B Purchase
KANNAN RAJ

Chief Executive Officer

Executive Director
10,000 +140.9%
4.20
US$42,000 		10,000 +140.9% 4.20 US$42,000
2020-02-21 2020-02-20 PlS Planned sale
Mamluk Roni
Non-Executive Director
82,186 -100.0%
4.54
US$373,124 		82,186 -100.0% 4.54 US$373,124
2019-12-23 2019-12-20 PlS Planned sale Mamluk Roni Non-Executive Director
61,139 -100.0%
5.51
US$336,876 		61,139 -100.0% 5.51 US$336,876
2019-10-17 2019-10-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
4.94
US$49,400 		10,000 -100.0% 4.94 US$49,400
2019-09-27 2019-09-27 B Purchase
LUDLAM WILLIAM

See Remarks
5,050 +74.8%
4.91
US$24,783 		5,050 +74.8% 4.91 US$24,783
2019-09-23 2019-09-20 PlS Planned sale
Mamluk Roni
50,000 -100.0%
5.59
US$279,500 		50,000 -100.0% 5.59 US$279,500
2019-08-21 2019-08-20 B Purchase Minick Scott Non-Executive Director
5,518 +6.8%
5.33
US$29,411 		5,518 +6.8% 5.33 US$29,411
2019-08-21 2019-08-19 B Purchase Minick Scott Non-Executive Director
4,300 +5.6%
5.02
US$21,586 		4,300 +5.6% 5.02 US$21,586
2019-07-17 2019-07-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
6.35
US$63,500 		10,000 -100.0% 6.35 US$63,500
2019-04-17 2019-04-16 PlS Planned sale
Mamluk Roni
10,000 -100.0%
5.31
US$53,100 		10,000 -100.0% 5.31 US$53,100
2019-04-02 2019-04-01 PP Planned purchase
LUDLAM WILLIAM

See Remarks
1,625 +31.7%
5.00
US$8,125 		1,625 +31.7% 5.00 US$8,125
2019-03-06 2019-03-05 PlS Planned sale
Mamluk Roni
5,000 -100.0%
5.00
US$25,000 		5,000 -100.0% 5.00 US$25,000
2019-01-23 2019-01-22 PlS Planned sale
Mamluk Roni
Non-Executive Director
5,000 -100.0%
3.67
US$18,370 		5,000 -100.0% 3.67 US$18,370
2018-12-21 2018-12-20 PP Planned purchase Fitzpatrick Mark J.

President and CEO

Executive Director
9,612 +inf%
2.50
US$24,030 		9,612 +inf% 2.50 US$24,030
2018-09-20 2018-09-20 B Purchase Minick Scott Non-Executive Director
13,000 +18.3%
3.09
US$40,170 		13,000 +18.3% 3.09 US$40,170
2018-09-20 2018-09-19 B Purchase Minick Scott Non-Executive Director
8,000 +12.7%
3.06
US$24,480 		8,000 +12.7% 3.06 US$24,480
2018-09-20 2018-09-18 B Purchase Minick Scott Non-Executive Director
4,000 +6.8%
3.07
US$12,280 		4,000 +6.8% 3.07 US$12,280
2018-06-20 2018-06-18 PlS Planned sale Mamluk Roni Non-Executive Director
2,389 -100.0%
1.46
US$3,484 		2,389 -100.0% 1.46 US$3,484
2018-03-20 2018-03-19 PlS Planned sale Mamluk Roni
2,389 -100.0%
1.53
US$3,655 		2,389 -100.0% 1.53 US$3,655
2017-12-19 2017-12-18 PlS Planned sale Mamluk Roni
2,389 -100.0%
1.75
US$4,181 		2,389 -100.0% 1.75 US$4,181
2017-10-26 2017-10-24 PlS Planned sale Mamluk Roni
2,389 -100.0%
2.27
US$5,430 		2,389 -100.0% 2.27 US$5,430
2017-09-22 2017-09-21 B Purchase Minick Scott
10,000 +20.3%
2.36
US$23,569 		10,000 +20.3% 2.36 US$23,569
2017-09-22 2017-09-20 B Purchase Minick Scott
15,000 +43.8%
2.38
US$35,690 		15,000 +43.8% 2.38 US$35,690
2015-07-23 2015-07-21 B Purchase 7-MED Health Ventures LP Large shareholder
93,750 +inf%
16.00
US$1,500,000 		93,750 +inf% 16.00 US$1,500,000
Explore more

More insider trading research around Chiasma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America